Two-Week Multimodal Prehabilitation Program Improves Perioperative Functional Capability in Patients Undergoing Thoracoscopic Lobectomy for Lung Cancer: A Randomized Controlled Trial
- PMID: 31348053
- DOI: 10.1213/ANE.0000000000004342
Two-Week Multimodal Prehabilitation Program Improves Perioperative Functional Capability in Patients Undergoing Thoracoscopic Lobectomy for Lung Cancer: A Randomized Controlled Trial
Abstract
Background: Patients with lung cancer often experience reduced functional capacity and quality of life after surgery. The current study investigated the impact of a short-term, home-based, multimodal prehabilitation program on perioperative functional capacity in patients undergoing video-assisted thoracoscopic surgery (VATS) lobectomy for nonsmall cell lung cancer (NSCLC).
Methods: A randomized controlled trial was conducted with 73 patients. Patients in the prehabilitation group (n = 37) received a 2-week multimodal intervention program before surgery, including aerobic and resistance exercises, respiratory training, nutrition counseling with whey protein supplementation, and psychological guidance. Patients in the control group (n = 36) received the usual clinical care. The assessors were blinded to the patient allocation. The primary outcome was perioperative functional capacity measured as the 6-minute walk distance (6MWD), which was assessed at 1 day before and 30 days after surgery. A linear mixed-effects model was built to analyze the perioperative 6MWD. Other outcomes included lung function, disability and psychometric evaluations, length of stay (LOS), short-term recovery quality, postoperative complications, and mortality.
Results: The median duration of prehabilitation was 15 days. The average 6MWD was 60.9 m higher perioperatively in the prehabilitation group compared to the control group (95% confidence interval [CI], 32.4-89.5; P < .001). There were no differences in lung function, disability and psychological assessment, LOS, short-term recovery quality, postoperative complications, and mortality, except for forced vital capacity (FVC; 0.35 L higher in the prehabilitation group, 95% CI, 0.05-0.66; P = .021).
Conclusions: A 2-week, home-based, multimodal prehabilitation program could produce clinically relevant improvements in perioperative functional capacity in patients undergoing VATS lobectomy for lung cancer.
Trial registration: ClinicalTrials.gov NCT03068507.
Comment in
-
Prehabilitation prior to lung cancer surgery: a small step forward.J Thorac Dis. 2019 Dec;11(12):5664-5665. doi: 10.21037/jtd.2019.12.54. J Thorac Dis. 2019. PMID: 32030295 Free PMC article. No abstract available.
-
Prehabilitation in lung cancer resection-are we any closer to the ideal program?J Thorac Dis. 2020 Apr;12(4):1628-1631. doi: 10.21037/jtd.2020.02.15. J Thorac Dis. 2020. PMID: 32395302 Free PMC article. No abstract available.
References
-
- Siegel R, Miller K, Jemal ACancer statistics, 2015. CA Cancer J Clin. 2015;65:29.
-
- Sommer MS, Trier K, Vibe-Petersen J, et al.Perioperative rehabilitation in operation for lung cancer (PROLUCA) - rationale and design. BMC Cancer. 2014;14:404.
-
- Carli F, Scheede-Bergdahl CPrehabilitation to enhance perioperative care. Anesthesiol Clin. 2015;33:17–33.
-
- Carli F, Charlebois P, Stein B, et al.Randomized clinical trial of prehabilitation in colorectal surgery. Br J Surg. 2010;97:1187–1197.
-
- Pouwels S, Fiddelaers J, Teijink JA, Woorst JF, Siebenga J, Smeenk FWPreoperative exercise therapy in lung surgery patients: a systematic review. Respir Med. 2015;109:1495–1504.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical